Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.


Kokkinou M(1), Beishon LC(2), Smailagic N(3), Noel-Storr AH(4), Hyde C(5), Ukoumunne O(6), Worrall RE(7), Hayen A(8), Desai M(9), Ashok AH(1)(10), Paul EJ(1)(11), Georgopoulou A(12), Casoli T(13), Quinn TJ(14), Ritchie CW(15).
Author information:
(1)MRC London Institute of Medical Sciences, Imperial College London, London, UK.
(2)Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
(3)Institute of Public Health, University of Cambridge , Cambridge, UK.
(4)Radcliffe Department of Medicine, University of Oxford , Oxford, UK.
(5)Exeter Test Group, College of Medicine and Health, University of Exeter Medical School, University of Exeter, Exeter , UK.
(6)NIHR CLAHRC South West Peninsula
(PenCLAHRC), University of Exeter Medical School, Exeter, UK.
(7)University of Oxford Medical School, Oxford, UK.
(8)Department of Psychology and Clinical Language Sciences, University of Reading, Reading, UK.
(9)Department of Experimental Psychology, University of Oxford, Oxford, UK.
(10)Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College , London, UK.
(11)Institute of Clinical Sciences
(ICS), Faculty of Medicine, Imperial College London, London, UK.
(12)Department of Surgery and Cancer, Imperial College London, London, UK.
(13)Center for Neurobiology of Aging, IRCCS INRCA, Ancona, Italy.
(14)Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
(15)Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.


Update of doi: 10.1002/14651858.CD010945.